Drug Research
Univercells launches cell & gene therapy CMDO Exothera with...
Univercells has launched a contract development and manufacturing organization (CDMO), Exothera, to support cell and gene therapy developers with process development and production of viral...
Packaging & Labelling
Turkish Cargo, the global air cargo brand, starts its...
Enjoying the widest direct cargo flight network of the worldamong the global air cargo carriers, Turkish Cargo continues to increase the number of destinations with...
Clinical Trials
CluePoints Central Statistical Monitoring Supports Business Continuity as Coronavirus...
CluePoints, the premier provider of Risk-Based Trial Execution (RBx) and Data Quality Oversight Software for clinical trials, announced that it has seen a dramatic increase...
Press Releases
Bormioli Pharma issues a binding offer to acquire GCL...
Bormioli Pharma announces the issuing of a Binding Offer for the acquisition of 100% of GCL Pharma, an Italian subsidiary of the Guala Closures Group,...
Clinical Trials
Zydus and XOMA Announce IL-2-Based Immuno-Oncology Therapy Licensing Agreement
Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology (IO) drug...
Drug Research
Coronavirus Drug Development Update from NanoViricides, Inc
NanoViricides, Inc. a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts...
Press Releases
EC approves Alnylams Givlaari for acute hepatic porphyria
The European Commission (EC) has approved Alnylam’s Givlaari (givosiran) for adults and adolescents with acute hepatic porphyria (AHP).
Givlaari was previously granted priority medicines designation by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.